114
M. Abbasi et al. / Journal of Organometallic Chemistry 822 (2016) 112e117
Fig. 1. UV spectra of NiCl2$6H2O I) in H2O, (II) in DMF; (III) in PEG; (IV) in PEG in the presence of KSCN; (V) in DMF in the presence of KSCN; (VI) and in PEG in the presence of PPh3.
As it is proposed in Scheme 1, Ni(SCN)2 is formed in the reaction
mixture from the reaction of NiCl2 with KSCN which subsequently
undergoes oxidative addition by insertion to aryl CeX bond to
produce Ni(IV) intermediate (1). This step is followed by reductive
elimination to give AreSCN and the Ni(II) catalyst as XeNieSCN
(cycle A). The starting Ni(SCN)2 catalyst, is regenerated by reacting
XeNieSCN with KSCN (cycle A). The in situ generated aryl mer-
captane (from the Ni2þ catalyzed hydrolysis of ArSCN) (path B)
undergoes arylation by second molecule of AreX to produce sym-
metric sulfide (cycle C). This process occurs through replacement of
halide anion of intermediate (1) by thiolate followed by reductive
elimination (cycle C). According to proposed mechanism presented
in Scheme 2, Ni(0) inserts itself into CeX bond of aryl halide to
produce AreNi(II)eX (cycle D). This intermediate is then converted
to AreNi(II)eSCN by replacement of halide by thiocyanate ion.
Reductive-elimination step, gives ArSCN along with regeneration of
Ni(0) catalyst (cycle D). ArSeNi(II)eCN is then generated by inser-
tion of Ni(0) into SeCN bond of in situ generated aryl thiocyanate
(cycle E). The intermediate (3) is subsequently produced via
oxidative addition of Ni (II) to the SeCN bond of the second
molecule of RSeCN. Finally, the reductive elimination of this in-
termediate takes place to give the target symmetric disulfide and
Ni(II) catalyst which in turn, undergoes reduction with DMF to
regenerate Ni(0) catalyst.
Chemical Companies. 1H NMR and 13C NMR spectra were recorded
in CDCl3 using a Bruker Avance DPX instrument (1H NMR 250 MHz,
13C NMR 62.5 MHz). Chemical shifts are reported in ppm (
d)
downfield from TMS. Coupling constants (J) are in Hertz. Elemental
analyses were run on a Thermo Finnigan Flash EA-1112 series. Thin-
layer chromatography was carried out on silica gel 254 analytical
sheets obtained from Fluka. Column chromatography was per-
formed on Merck Kiesel gel (230e270 mesh).
4.2. General procedure for synthesis of disulfides
KSCN (2.2 mmol) was added to a magnetically stirred mixture of
an aryl halide (2 mmol), NiCl2$6H2O (0.6 mmol, 30 mol%, 0.143 g)
and DMAP (0.8 mmol, 40 mol%, 0.098 g) in DMF (2 mL) at 140 ꢀC.
The stirring was continued until the starting halide was completely
consumed. Next, the reaction mixture was diluted with water
(1 mL) and extracted with 1:1 EtOAc/hexane (4 ꢂ 2 mL). The
organic extracts were combined, concentrated and purified by
chromatography on silica gel. The desired disulfides were produced
in 79e92% yields (Table 2).
4.2.1. 1,2-Diphenyldisulfane (Table 2, entry 1)
MP: 57e58 ꢀC (Lit. 59e60 ꢀC) [51]. 1H NMR (250 MHz, CDCl3):
dH ¼ 7.53e7.49 (m, 4H), 7.34e7.23 (m, 6H) ppm. 13C NMR
(62.9 MHz, CDCl3): dC ¼ 137.0, 129.4, 127.5, 127.1 ppm. Anal. Calcd
for (C12H10S2): C, 66.02; H, 4.62; S, 29.37. Found: C, 66.15; H, 4.52; S,
29.33.
3. Conclusion
In summary, the first Ni-catalyzed coupling of aryl halides and
KSCN was developed. Symmetric diaryl-sulfides or disulfides were
synthesized selectively in high yields by treatment of aryl halides
with KSCN in the presence of NiCl2$6H2O and DMAP in PEG-200
and DMF, respectively. A variety of aryl bromides and iodides
bearing the electron donating and withdrawing groups were
screened without difficulty. The method is simple, high yielding
which tolerates a variety of functional groups on the aryl rings.
4.2.2. 1,2-Di-p-tolyldisulfane (Table 2, entry 3)
MP: 43e45 ꢀC (Lit. 41e45 ꢀC) [74]. 1H NMR (250 MHz, CDCl3):
dH ¼ 7.36 (d, J ¼ 8.6 Hz, 4H), 7.07 (d, J ¼ 8.6 Hz, 4H), 2.28 (s, 6H) ppm.
13C NMR (62.9 MHz, CDCl3): dC ¼ 137.4, 134.0, 129.8, 128.6,
21.1 ppm. Anal. Calcd for (C14H14S2): C, 68.25; H, 5.73; S, 26.02.
Found: C, 68.29; H, 5.83; S, 25.88.
4.2.3. 1,2-Bis(4-methoxyphenyl)disulfane (Table 2, entry 2)
MP: 40e43 ꢀC (Lit. 41e43 ꢀC) [51]. 1H NMR (250 MHz, CDCl3):
dH ¼ 7.34 (d, J ¼ 8.8 Hz, 4H), 6.89 (d, J ¼ 8.8 Hz, 4H), 3.83 (s, 6H)
ppm. 13C NMR (62.9 MHz, CDCl3): dC ¼ 159.1, 132.8, 127.5, 114.7,
55.5 ppm. Anal. Calcd for (C14H14O2S2): C, 60.40; H, 5.07; S, 23.03.
Found: C, 60.23; H, 5.17; S, 23.13.
4. Experimental
4.1. General information
Chemicals were purchased from Merck, Fluka and Acros